Teva’s turn to defend brand-name drug patents

A board to discuss the Multiple Sclerosis modifying drug Copaxone

Teva’s turn to defend brand-name drug patents

Postby MSUK » Mon Jul 25, 2011 7:05 am

Image


Tables are Turned: Teva Pharmaceutical Industries mostly makes generic drugs, but now finds itself acting like Big Pharma — defending the patent for a brand-name drug in order to stave off the threat of generic competition, the Wall Street Journal reports.

Mylan and Momenta are challenging the validity of Teva’s patents for the multiple-sclerosis drug Copaxone, hoping to sell generic copies before the patents expire in 2014 and 2015, the paper says.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1903
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2092
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Re: Teva’s turn to defend brand-name drug patents

Postby its2much » Sat Oct 08, 2011 6:14 pm

What's happening with this lawsuit?
User avatar
its2much
Getting to Know You...
 
Posts: 23
Joined: Fri Aug 05, 2011 3:00 pm


Return to Copaxone

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users